Moxetumomab pasudotox-tdfk Intravenous and Oxaprozin Potassium
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Oxaprozin Potassium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: oxaprozin
Brand name: Daypro
Synonyms: Oxaprozin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Oxaprozin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Oxaydo
- Moxetumomab pasudotox-tdfk Intravenous-Oxazepam
- Moxetumomab pasudotox-tdfk Intravenous-Oxcarbazepine
- Moxetumomab pasudotox-tdfk Intravenous-Oxcarbazepine Extended-Release Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Oxcarbazepine Oral Suspension
- Oxaprozin Potassium-Moxifloxacin
- Oxaprozin Potassium-Moxifloxacin (Systemic)
- Oxaprozin Potassium-Moxifloxacin Hydrochloride
- Oxaprozin Potassium-Moxifloxacin Injection
- Oxaprozin Potassium-Moxifloxacin Intravenous
- Oxaprozin Potassium-Moxifloxacin Tablets